Estrogen Blockers Market
According to Intent Market Research, the Estrogen Blockers Market is expected to grow from USD 13.9 billion in 2023 at a CAGR of 6.8% to touch USD 22.1 billion by 2030. The Estrogen Blockers Market is dominated by key players such as AstraZeneca, Novartis, Pfizer, Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb, AbbVie Inc., Bayer AG, Amgen Inc., Ferring Pharmaceuticals, Sun Pharmaceutical Industries, Ipsen, Teva Pharmaceutical Industries, Mylan N.V.